Kenvue, US49177J1025

Kenvue Stock - weekly outlook after a soft midday quote

17.06.2026 - 16:15:30 | ad-hoc-news.de

Kenvue’s stock is trading with a delayed market quote, while the company’s consumer-health portfolio remains centered on Neutrogena, Tylenol, Listerine and Johnson’s. Wednesday’s focus falls on operations and strategy.

Kenvue, US49177J1025
Kenvue, US49177J1025

Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 16:13 UTC. Details in the imprint.

Kenvue (US49177J1025) is the focus of a quiet Wednesday session. The company’s investor-relations quote page shows a delayed price of $18.14 as of 06/17/2026, 4:00 PM ET.

Go deeper

All news and data on Kenvue stock

Use this hub for background, price data and new filings tied to Kenvue’s shares.

What Reuters did not flag

Kenvue did not have a fresh Reuters, Bloomberg, or company filing hook in the live search set used for this update. That leaves Wednesday’s operations-and-strategy lens as the main angle.

The absence of a new event matters because the stock is already being tracked through a narrow band of routine market data and portfolio execution comments.

Operations and strategy

Kenvue’s business still rests on familiar consumer-health brands, not a single product cycle. That makes execution on pricing, distribution, and margins more important than short-term headlines.

The company’s own materials frame the portfolio around household names such as Neutrogena, Aveeno, OGX, Zyrtec, Tylenol, and Listerine. Those brands anchor a mix of skincare, self-care, and oral-health products.

What the quote shows

MarketBeat showed Kenvue stock at $18.42 at 11:24 AM Eastern, while the investor-relations quote page listed $18.14 at 4:00 PM ET. The different timestamps point to two separate quote snapshots, not a single official close.

MarketBeat also cited a consensus price target of $19.33 and a Hold rating. That keeps the stock in a measured lane rather than a headline-driven one.

What the company sells

Kenvue sells over-the-counter health, self-care, and skin-care products. Its portfolio includes Tylenol, Neutrogena, Listerine, and Band-Aid, which makes the company a classic consumer-health name rather than a medical-device story.

Where the stock trades today

The shares of Kenvue (US49177J1025) trade on the NYSE at $18.14 as of 06/17/2026, 4:00 PM ET.

Kenvue at a glance

  • Company: Kenvue Inc.
  • ISIN: US49177J1025
  • Ticker: KVUE
  • Venue: NYSE
  • Price (as of 06/17/2026, 4:00 PM ET): $18.14
  • Sector / Industry: Consumer Staples / Household & Personal Products
  • Index membership: not verified
  • Next earnings date: not officially scheduled

More on Kenvue stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US49177J1025 | KENVUE | boerse | 69563418 | bgmi